The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 07, 2017

Filed:

Sep. 14, 2012
Applicants:

Linda Eastwood, Beverly Hills, CA (US);

Harold Coons, Beverly Hills, CA (US);

James M. Sinclair, Beverly Hills, CA (US);

Matthew D. Bacchetta, New York, NY (US);

Gopal Singh, New York, NY (US);

Inventors:

Linda Eastwood, Beverly Hills, CA (US);

Harold Coons, Beverly Hills, CA (US);

James M. Sinclair, Beverly Hills, CA (US);

Matthew D. Bacchetta, New York, NY (US);

Gopal Singh, New York, NY (US);

Assignees:

YES, INC., Beverly Hills, CA (US);

THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 15/40 (2006.01); A61L 15/38 (2006.01); A61L 15/44 (2006.01); A61K 31/722 (2006.01); A61K 36/185 (2006.01); A61K 36/28 (2006.01); A61K 45/06 (2006.01); A61K 38/48 (2006.01); A61K 31/185 (2006.01); A61K 33/06 (2006.01); A61L 15/18 (2006.01); A61L 15/22 (2006.01); A61K 38/36 (2006.01); A61L 15/28 (2006.01); A61L 15/32 (2006.01);
U.S. Cl.
CPC ...
A61L 15/38 (2013.01); A61K 31/185 (2013.01); A61K 31/722 (2013.01); A61K 33/06 (2013.01); A61K 36/185 (2013.01); A61K 36/28 (2013.01); A61K 38/363 (2013.01); A61K 38/4833 (2013.01); A61K 45/06 (2013.01); A61L 15/18 (2013.01); A61L 15/225 (2013.01); A61L 15/28 (2013.01); A61L 15/32 (2013.01); A61L 15/40 (2013.01); A61L 15/44 (2013.01); A61L 2400/04 (2013.01); C12Y 304/21005 (2013.01);
Abstract

The present invention provides hemostatic compositions comprising components of the flowers of pharmaceutical chamomile (), the leaves of dioecious nettle (), kaolin, chitosan, fibrinogen and thrombin. Further inclusion of a biocompatible polymeric base, particularly an alignate, generates a composition with superior and broad spectrum hemostatic capabilities, including the ability to arrest arterial hemorrhage. The invention further provides methods of using the inventive compositions in to reduce or stop bleeding, as well as a variety of apparatuses useful in hemostatic contexts that incorporate the inventive compositions. In one particular embodiment, the invention provides hemostatic dressings in which a polymeric layer incorporating chamomile, nettle, kaolin, chitosan, fibrinogen and thrombin components is applied to a textile or fabric material, for example a non-woven viscose.


Find Patent Forward Citations

Loading…